Skip to content

Clinical trials

Phase 3 Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20062
20091
20161
20171
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group7
European Organisation for Research and Treatment of Cancer - EORTC4
Gustave Roussy, Cancer Campus, Grand Paris1
National Cancer Institute (NCI)1
University Hospital Tuebingen1
Yizhuo Zhang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma15
Sarcoma9
Sarcoma, Synovial5
Fibrosarcoma4
Hemangiosarcoma4
Histiocytoma, Malignant Fibrous4
Leiomyosarcoma4
Liposarcoma4
Neurofibrosarcoma4
Rhabdomyosarcoma, Alveolar2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.